Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009
More News related to CLDX
- Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009
- Merriman Curhan Positive On Celldex Therapeutics (CLDX) After Results and Ahead of Events
- Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
- Celldex Therapeutics (CLDX) Announces Positive Results From Phase Studies of CDX-1307
- Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307
More News related to MERR
- Merriman Curhan Ford to Present at 2nd Annual LD MICRO Conference
- Merriman Curhan Ford Reports NASDAQ Notice -- Plans to Modify Warrants and Return to Compliance
- LD MICRO to Host 2nd Annual Growth Conference
- Merriman Curhan Ford Names Former Hewlett-Packard Senior Executive Duane Zitzner to its Advisory Board
- Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedix's $20.7 Million Equity Financing
More News related to Press Releases
- Top 10 News Items 11/23-11/27: Dubai Debt Fallout; Gold; GDP Revised Lower; Diedrich Coffee Bidding War
- Trading Radar for 11/30: Inergy Holdings (NRGP), Golar (GLNG), Omnivision (OVTI), Knightsbridge (VLCCF) Report
- Notable Mergers and Acquisitions of the Day for 11/27: F, S/IPCS, STAR/CSCO, HRAY
- Notable Analyst Rating Changes 11/27: TIF, QLTI Upgraded; FSNM, RGFC Downgraded
- Notable ETF Movers *Special Dubai World Edition* 11/27: UUP Higher; GAF, EEM, FXI, XLF Lower
NEEDHAM, Mass.--(BUSINESS WIRE)-- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at Merriman Curhan Ford's 6th Annual Investor Summit at the Sofitel Hotel, New York City on Tuesday, November 10, 2009 at 2:40 pm, EST.
A live webcast of the 15-minute audio presentation will be available online at http://www.wsw.com/webcast/mcm12/cldx/ and on the "Presentations" page of the Investor Information section of Celldex's website at http://www.celldextherapeutics.com. An archive of the webcast will be available via Celldex's website for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
About Merriman Curhan Ford
Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology. For more information, please go to www.mcfco.com.
Source: Celldex Therapeutics, Inc.
Related Categories
Press ReleasesStocks Mentioned
-0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
